Riboflavin 5-phosphate Ophthalmic Solution — FDA Drug Shortage

To Be Discontinued — Glaukos Corporation

The FDA lists a drug shortage record for Riboflavin 5-phosphate Ophthalmic Solution (ophthalmic solution) from Glaukos Corporation with status To Be Discontinued. The shortage was first posted on Jan 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Glaukos Corporation
Package NDC
25357-025-03
Dosage Form
Ophthalmic Solution
Presentation
Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)
Initial Posting
Jan 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.